Last reviewed · How we verify
NCT06693622
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
trial testing Patient survey in Gastro Esophageal Reflux Disease in 556 participants. Currently enrolling.
1 March 2029
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 556 |
| Start date | 1 November 2024 |
| Primary completion | 1 March 2029 |
| Estimated completion | 1 March 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Patient survey
Conditions studied
- Gastro Esophageal Reflux Disease — all drugs for Gastro Esophageal Reflux Disease →
- Barrett Esophagus — all drugs for Barrett Esophagus →
Sponsor
University of Colorado, Denver
Who can join
Adults 18 to 89, any sex, with Gastro Esophageal Reflux Disease or Barrett Esophagus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06693622
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastro Esophageal Reflux Disease
Currently open trials in the same condition.
- NCT06564558 — The Effect of Postural Correction On Gastroesophageal Reflux Disease · NA · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06693622 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 18 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06693622.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing